Our Leadership Team
Dean Park is the Founder of Mezzion Pharma Co. Ltd. and also serves as the Chief Executive Officer. Dean has also founded and served as Chief Executive Officer and/or President for a number of other successful international companies, including AIA Capital Korea, Far East Investment, Hutchison Corporate Access and Ricco Nine. Dean has previously served as Vice President and Director of the investment banking group at Merrill Lynch Capital Markets.
Dean Park, CEO
John Presser is the Chief Business Officer at Mezzion Pharma Co. Ltd. leading business development, commercial and external engagements. John has over 20 years of executive leadership responsibilities in BD&L, commercial and analytics at Boehringer Ingelheim. Prior to that John worked in R&D for Amylin Pharmaceuticals (now part of Astra Zeneca) and the SALK Institute.
John Presser, MBA
Kelly Williams is the Director of Global Clinical Operations at Mezzion Pharma Co. Ltd., with more than 25 years of experience leading clinical operations. Kelly has experience working in both big and small pharmaceuticals, from Mallinckrodt, Merk, to Veru. She has extensive experience managing clinical trials, CROs and other trial vendors.
Kelly Williams
John Hariadi, MD, MMCi
John Hariadi is the Chief Medical Officer and Senior Vice President of Global Regulatory Affairs at Mezzion Pharma Co. Ltd., with more than 30 years of experience leading healthcare organizations to include the U.S. Food and Drug Administration as well as most recently at Johnson and Johnson.